You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 8,487,129


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,487,129
Title:Heterodimers of glutamic acid
Abstract: Compounds of Formula (Ia) ##STR00001## wherein R is a C.sub.6-C.sub.12 substituted or unsubstituted aryl, a C.sub.6-C.sub.12 substituted or unsubstituted heteroaryl, a C.sub.1-C.sub.6 substituted or unsubstituted alkyl or --NR'R', Q is C(O), O, NR', S, S(O).sub.2, C(O).sub.2 (CH2)p Y is C(O), O, NR', S, S(O).sub.2, C(O).sub.2 (CH2)p Z is H or C.sub.1-C.sub.4 alkyl, R' is H, C(O), S(O).sub.2, C(O).sub.2, a C.sub.6-C.sub.12 substituted or unsubstituted aryl, a C.sub.6-C.sub.12 substituted or unsubstituted heteroaryl or a C.sub.1-C.sub.6 substituted or unsubstituted alkyl, when substituted, aryl, heteroaryl and alkyl are substituted with halogen, C.sub.6-C.sub.12 heteroaryl, --NR'R' or COOZ, which have diagnostic and therapeutic properties, such as the treatment and management of prostate cancer and other diseases related to NAALADase inhibition. Radiolabels can be incorporated into the structure through a variety of prosthetic groups attached at the X amino acid side chain via a carbon or hetero atom linkage.
Inventor(s): Babich; John W. (Cambridge, MA), Zimmerman; Craig N. (Cambridge, MA), Maresca; Kevin P. (Cambridge, MA)
Assignee: Molecular Insight Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:13/294,677
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

United States Patent 8,487,129: A Detailed Analysis

Overview of the Patent

United States Patent 8,487,129, titled "Heterodimers of glutamic acid," is a patent that deals with specific chemical compounds, particularly heterodimers of glutamic acid, and their applications. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Scope of the Patent

The patent focuses on the development and use of heterodimers of glutamic acid, which are compounds composed of two different subunits linked together. These compounds are particularly relevant in the field of biochemistry and pharmaceuticals, especially in targeting specific cellular receptors.

Biological Assessments

The patent includes detailed biological assessments of lead compounds, such as their binding affinity to PSMA-positive LNCaP cells. This is crucial for understanding the potential therapeutic applications of these compounds, particularly in cancer treatment[1].

Claims of the Patent

The claims section of the patent outlines the specific aspects of the invention that are protected. Here are some key points:

Compound Structure

The patent claims cover the structure of the heterodimers, including the specific linkages and substitutions on the glutamic acid molecules. These claims are detailed to ensure that the unique configuration of the compounds is protected[1].

Synthesis and Preparation

The patent also claims methods for synthesizing these heterodimers, which is essential for their practical application. This includes various chemical reactions and conditions necessary to produce the desired compounds[1].

Therapeutic Applications

The claims extend to the therapeutic uses of these compounds, particularly in targeting PSMA-positive cells. This indicates the potential for these compounds in cancer therapy, especially in prostate cancer treatment[1].

Patent Landscape Analysis

Prior Art and Saturation

A patent landscape analysis reveals that the area of biochemistry and pharmaceuticals, especially targeting PSMA-positive cells, is highly saturated. This means there are numerous existing patents and ongoing research in this field, making it crucial to identify unique aspects of the invention to avoid infringement and ensure novelty[3].

Competitors and Market Position

The landscape analysis also helps in identifying key competitors and their patent portfolios. For instance, companies focusing heavily on niche technologies related to PSMA targeting may have significant patent holdings, which could impact the market position of the patented heterodimers of glutamic acid[3].

Strategic Insights

Long-Term Decisions

A comprehensive patent landscape analysis can guide long-term decisions about the direction of research and development. It helps in identifying areas of high patent saturation and suggests pivoting to newer, less crowded inventive spaces to maintain competitive advantage[3].

Avoiding Infringement

Understanding the patent landscape is critical for avoiding infringement on existing patents. This involves a thorough search of prior art and ensuring that the claimed invention is novel and non-obvious over the existing state of the art[4].

Determining Inventorship

Legal Implications

The determination of inventorship is a critical aspect of patent law. For a patent like US 8,487,129, it is essential to identify the true and only inventors who conceived the idea and reduced it to practice. Incorrect or incomplete identification of inventors can lead to the patent being invalid or unenforceable[2].

Conception and Reduction to Practice

Inventorship focuses on the conception step, which is the formation of a definite and permanent idea of the complete and operative invention. This idea must be sufficiently clear to allow one with ordinary skill in the field to reduce it to practice without undue experimentation[2].

Tools for Patent Searching

Patent Public Search

Tools like the Patent Public Search application provided by the USPTO are invaluable for conducting thorough patent searches. This tool offers enhanced access to prior art and improves the overall patent searching process[4].

Global Dossier

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related data. This is particularly useful for understanding the global patent landscape[4].

Key Takeaways

  • Unique Compounds: The patent protects unique heterodimers of glutamic acid with specific therapeutic applications.
  • Highly Saturated Field: The area of biochemistry and pharmaceuticals targeting PSMA-positive cells is highly saturated, requiring careful analysis to avoid infringement.
  • Strategic Decisions: Patent landscape analysis is crucial for making long-term R&D decisions and identifying new inventive spaces.
  • Inventorship: Correct determination of inventorship is vital to ensure the patent's validity and enforceability.
  • Advanced Search Tools: Utilizing advanced search tools like Patent Public Search and Global Dossier is essential for thorough patent analysis.

FAQs

What is the main focus of United States Patent 8,487,129?

The main focus of this patent is on the development and use of heterodimers of glutamic acid, particularly their therapeutic applications in targeting PSMA-positive cells.

Why is patent landscape analysis important for this patent?

Patent landscape analysis is crucial for understanding the competitive environment, avoiding infringement, and making strategic R&D decisions in a highly saturated field.

How does incorrect inventorship affect a patent?

Incorrect or incomplete identification of inventors can lead to the patent being invalid or unenforceable due to deceptive intent or failure to name the true inventors.

What tools are available for conducting a thorough patent search?

Tools such as the Patent Public Search application, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are available for conducting thorough patent searches.

What is the significance of the Global Dossier service?

The Global Dossier service provides access to file histories of related applications from participating IP Offices, offering a comprehensive view of the patent family and related data.

Sources

  1. US8487129B2 - Heterodimers of glutamic acid - Google Patents
  2. Determining Inventorship for US Patent Applications - Oregon State University
  3. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP
  4. Search for patents - USPTO - United States Patent and Trademark Office
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,487,129

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Progenics Pharms Inc PYLARIFY piflufolastat f-18 SOLUTION;INTRAVENOUS 214793-001 May 26, 2021 RX Yes Yes 8,487,129 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.